Trials / Terminated
TerminatedNCT01354678
Intramyocardial Multiple Precision Injection of Bone Marrow Mononuclear Cells in Myocardial Ischemia
Phase 1 Study to Evaluate the Efficacy and Safety of Intramyocardial Multiple Precision Injection of Bone Marrow Mononuclear Cells in Myocardial Ischemia
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health · Academic / Other
- Sex
- All
- Age
- 18 Years – 69 Years
- Healthy volunteers
- Not accepted
Summary
Randomised placebo-controlled study of efficiency and safety of bone marrow mononuclear cells transplantation by intramyocardial multiple precision injection in ischemic heart failure patients.
Detailed description
The increase of prevalence of heart failure in human population requires to develop new and effective methods of treatment. One of them is stem cells transplantation into a myocardial tissue, which cause the improvement of contractility, myocardial remodelling after myocardial infarction (MI), dilated cardiomyopathy, etc. Use of autologous stem cells does not require of immunosuppressive therapy and does not correlate with some ethical problems. Clinical application of mesenchymal stem cells always requires a step of culturing, which is associated with increased risk of contamination Therefore haemopoietic stem cells, endothelial progenitor cells or mononuclear bone marrow cells are often used to be transplant for treatment of heart failure (HF) patients.Using NOGA XP Cardiac Navigation System improves specificity of transplantations, that is decisive.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | NOGA XP Cardiac Navigation System | Intramyocardial multiple precision injection of bone marrow mononuclear cells |
| PROCEDURE | NOGA XP Cardiac Navigation System | Intramyocardial multiple precision injection with placebo |
Timeline
- Start date
- 2011-05-01
- Primary completion
- 2018-10-01
- Completion
- 2019-12-01
- First posted
- 2011-05-17
- Last updated
- 2020-02-13
Locations
1 site across 1 country: Russia
Source: ClinicalTrials.gov record NCT01354678. Inclusion in this directory is not an endorsement.